Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...
Non-alcoholic fatty liver disease (NAFLD) occurs when excess fat accumulates in liver cells in people who consume little or no alcohol. NAFLD is associated with various metabolic risk factors ...
The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent ...
MASLD, which was known until recently as nonalcoholic fatty liver disease, is estimated to affect nearly 4 in 10 people worldwide. It is the fastest-growing reason that people require liver ...
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global cause of chronic liver disease. The prevalence of ...
The Union Health Ministry has introduced revised operational guidelines and a training module for Non-Alcoholic Fatty Liver Disease (NAFLD) to enhance patient care. NAFLD is a growing public ...